Acute and long-term outcomes of percutaneous balloon aortic valvuloplasty for the treatment of severe aortic stenosis
| Autor: | Marzena, Daniec, Bartłomiej, Nawrotek, Danuta, Sorysz, Tomasz, Rakowski, Artur, Dziewierz, Łukasz, Rzeszutko, Paweł, Kleczyński, Jarosław, Trębacz, Marek, Tomala, Krzysztof, Żmudka, Dariusz, Dudek |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Aged
80 and over Balloon Valvuloplasty Male Time Factors Hemodynamics Stroke Volume Aortic Valve Stenosis Recovery of Function Severity of Illness Index Ventricular Function Left Treatment Outcome Echocardiography Aortic Valve Humans Female Hospital Mortality Poland Prospective Studies Registries Aged |
| Zdroj: | Catheterization and cardiovascular interventions : official journal of the Society for Cardiac AngiographyInterventions. 90(2) |
| ISSN: | 1522-726X |
| Popis: | This study aimed to evaluate the indications, short- and long-term outcomes of balloon aortic valvuloplasty (BAV) in patients with severe aortic stenosis (AS).A cohort of 112 patients with AS underwent 114 BAV procedures between October 2012 and July 2015 in two Polish interventional cardiology centers. Clinical and echocardiographic data were prospectively collected within 1, 6, and 12 months follow-up.BAV was performed as a bridge to TAVI (51.8%), surgical aortic valve replacement (AVR, 5.4%), before urgent noncardiac surgery (8.0%), for symptom relief (33.0%) and cardiogenic shock (1.8%). Periprocedural, in-hospital, 1-, 6-, 12-month mortality were 2.7%; 8.9%; 8.9%; 16.9%; 22.3%, respectively. Serious periprocedural adverse events occurred in 18.8% of patients. After the procedure, mean aortic valve area (AVA) increased from 0.59 ± 0.18 to 0.82 ± 0.24 cmBAV is a useful procedure in high-risk AS patients, where achieved effects can be sufficient in bridging patients for TAVI/AVR. © 2016 Wiley Periodicals, Inc. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text